Clinical Trials Directory

Trials / Completed

CompletedNCT04333797

Psychiatry of Transition in a World in Transition

Multicentre Prospective Cohort Study Assessing Risk and Protective Factors to Develop Psychopathology in Transitional Age Youth

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
252 (actual)
Sponsor
Queen Fabiola Children's University Hospital · Academic / Other
Sex
All
Age
17 Years – 17 Years
Healthy volunteers
Accepted

Summary

This clinical study evaluates risk and protective factor to develop psychopathology in transitional age youth. 300 patients will be recruited at the age of 17 years old and assessed at baseline and 2 years later.

Detailed description

Emerging adults are a particularly at-risk population in mental health. Transitional age youth have specific needs, not currently covered between child and adolescent mental health services (CAMHS) and adult mental health services (AMHS), mainly because of existing barriers. Movements from one to the other must be planned to achieve optimal patient care. Our project aims to identify clinical dimensional characteristics contributing to the development of psychopathology during the transition period. Continuities, discontinuities and resilience factors will be explored. The final purpose is to develop a non-stigmatizing approach to reduce rejection from youths in psychopathological suffering and increase social inclusion. The transversal and trans-diagnostic approach consists of a dimensional evaluation: 300 youth at the age of 17 will be included in a cohort of in-patients, out-patients and control group. Participants will be assessed at baseline and 2 years later. The primary outcome is based on Health of the Nation Outcome Scale for Children and Adolescents, measuring mental health care need, and WHO Quality of Life assessment. The secondary outcomes include the assessment of dimensions representing risk or protective factors to develop psychopathology and evolution of mental health status during transition age. Baseline evaluation consists in internalizing/externalizing symptoms, impulsivity/compulsivity, emotion regulation, cognitive functioning, social and family functioning, developmental, medical and trauma history. At follow-up, mental health pathways and transition results will be described.

Conditions

Interventions

TypeNameDescription
OTHERRisk and Protective Factors AssessmentFirst assessment at baseline (T0) - 17 y.o. Follow-up 2 years later (T1) - 19 y.o.

Timeline

Start date
2020-06-10
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2020-04-03
Last updated
2026-01-07

Locations

4 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04333797. Inclusion in this directory is not an endorsement.